Dr Heyland published a multicenterstudy in JAMDA to identify clinician barriers to participating in goal of care discussions in Long-Term care. Click here to read more.
Dr Heyland recently published a RCT in CMJA evaluating the decision aid, www.planwellguide.com. He evaluated the efficacy of a planwelguide as a decision support tool in increasing the completion of a advanced medical care planning and improving decisional outcomes in primary care settings. Click here to read more.
Dr Heyland submitted an article highlighting some of the ways people can prepare for the pandemic, specifically preparing for serious illness. The key factor to prepare for serious illness is based around the notion of learning and understanding how medical decisions are made when seriously ill, along with what to say and how best to work with doctors, to ensure the medical care that is right for you or a loved one is obtained. Planning for end of life care, when you know for certain you are dying, is not the same as planning for serious illness. COVID-19 is an example of a serious illness where there is a probability of death but as well as a probability of survival. Click here
Dr Heyland recently had a commentary published in the Lancet regarding advanced care planning. The article highlights the importance behind advance care planning (ACP) and how we all need to do it more, however, we also need to be doing it differently.The way to advance and move forward involves more robust, reliable, and useful tools that help patients establish their authentic values and transparently connects those values to possible treatment options made in the context of uncertainty. To read the full article visit the e-publication , here
RE-ENERGIZE now has 53 active sites participating in the trial. We have recuited 947 participants to date!
SUSTAIN has 92% of enrollment completed! A new sub-study has been implemented looking at physical outcomes in post cardiac surgery patients
IMPACT has concluded its enrollment. We are working on cleaning data and preparing to start the analysis of the data.
NEXIS has reached 48% of its recruitment target.
EFFORT has 73 participanting sites across 15 countries. We have enrolled 679 participants!
VICTORY We are initiating a pilot study that will examine the feasibility and safety of high does vitamin C in severely burned patients.